Data Sheet
GW0742 – Solution, 600mg (20mg/mL)
| Application | Potent PPARβ and PPARδ agonist |
| CAS | 317318-84-6 |
| Molar Mass | 471.5 g/mol |
| Chemical Formula | C21H17F4NO3S2 |
| IUPAC Name | 2-[4-[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]acetic acid |
| Synonyms | GW0742, 317318-84-6, GW 0742, GW-0742, GW0742X, GW610742, GW-0742X, CHEMBL38508, CHEBI:79991, {4-[({2-[3-Fluoro-4-(Trifluoromethyl)phenyl]-4-Methyl-1,3-Thiazol-5-Yl}methyl)sulfanyl]-2-Methylphenoxy}acetic Acid, SR-05000000447, 3tkm, GW 0742X, GWdelta 0742, GW 610742, GW-610742, DSSTox_CID_20760, DSSTox_RID_79591, DSSTox_GSID_40760, MLS006011159 |
| Storage | Store at room temperature, tightly sealed, away from heat, light and moisture. |
| Solubility | Soluble in DMSO, PEG 400 |
| Organoleptic Profile | Clear liquid |
| Physical Form | Solution in PEG400, contains BHT for stability purposes |
| Specification | GW0742 20mg/mL ±10% |
| Terms | This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering. |
PPARδ Agonist Research Compound for Metabolic and Endurance Studies
GW0742 is a research-grade small molecule widely studied for its potential relevance in PPARδ receptor signaling, lipid metabolism research, endurance physiology models, and mitochondrial bioenergetics investigations. As a compound of interest in metabolic science and performance biology, GW0742 has attracted scientific attention in studies involving fatty acid oxidation pathways, energy utilization signaling, and exercise-associated molecular regulation.
Presented in solution format for laboratory research applications, GW0742 has been investigated in models involving PPARδ-mediated mechanisms, metabolic efficiency pathways, and endurance-associated signaling research. Its investigational profile has made it a notable compound in advanced metabolic research.
Supplied as a research-grade solution for analytical and laboratory applications.
Common Research Areas
- PPARδ Signaling Research
- Lipid Metabolism Studies
- Endurance Physiology Investigation
- Mitochondrial Function Models
- Advanced Metabolic Research
How GW0742 Works
GW0742 has been studied for its potential interaction with pathways associated with PPARδ receptor signaling, lipid metabolism, and energy regulation. Researchers have explored its relevance in models involving fatty acid utilization pathways, mitochondrial signaling, and endurance-associated research.
Its pathway-focused profile has made GW0742 a recurring subject in advanced research science.
Research Overview
GW0742 has been investigated across a range of research models involving metabolism, bioenergetics, and endurance pathways.
Areas of scientific interest include:
- PPARδ pathway studies
- Lipid metabolism investigations
- Endurance research models
- Mitochondrial mechanism studies
- Energy regulation pathway research
Its broad research relevance continues to make it a notable compound in research science.
GW0742 vs Related Compounds
GW0742 vs Cardarine (GW501516)
GW0742 is often researched as a related analogue, while Cardarine is commonly investigated as a foundational PPARδ agonist compound.
GW0742 vs SR9009
SR9009 has drawn interest in Rev-Erb pathway investigations, whereas GW0742 is more strongly associated with PPARδ-mediated metabolic research.
Frequently Asked Questions
What is GW0742 studied for?
It is commonly researched in PPARδ signaling, lipid metabolism, endurance physiology, and mitochondrial-associated models.
What type of compound is GW0742?
GW0742 is classified as a PPARδ receptor agonist.
How should GW0742 solution be stored?
Research solutions are generally stored in cool, dry conditions protected from heat and light according to laboratory handling protocols.
